Decreased expression of the seven ARP2/3 complex genes in human gastric cancers

Atsushi Kaneda1, Michio Kaminishi, Takashi Sugimura

  • 1National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

Cancer Letters
|July 29, 2004
PubMed

Insights

Expression of Arp2/3 complex genes, crucial for actin organization, is consistently decreased in human gastric cancers. This reduction in actin regulators may contribute to cancer development and altered cell morphology.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Arp2/3 complex and filamins are key regulators of the actin cytoskeleton, influencing cell shape and movement.
  • Previous work indicated reduced expression of p41-Arc (Arp2/3 subunit) and FLNc (filamin) in gastric cancers.

Purpose of the Study:

  • To investigate the expression levels and methylation status of all seven Arp2/3 complex subunit genes in human gastric cancers.
  • To determine the correlation between Arp2/3 complex gene expression and gastric cancer phenotypes.

Main Methods:

  • Quantitative real-time RT-PCR was used to analyze gene expression in 32 primary gastric cancers and 8 cell lines.
  • Methylation-specific PCR was employed to assess CpG island methylation in the 5' regions of the Arp2/3 complex genes.

Main Results:

  • All seven Arp2/3 complex subunit genes showed significantly decreased expression in gastric cancer samples.
  • Reduced expression of at least one subunit was observed in all 32 primary samples, with 25 showing decreased expression in four or more subunits.
  • No significant methylation was detected in the CpG islands of the analyzed genes (except potentially p41-Arc), suggesting methylation is not the primary driver of downregulation.

Conclusions:

  • The consistent downregulation of Arp2/3 complex genes in gastric cancer suggests a potential role in the development of dysplastic morphology and cancer progression.
  • These findings highlight the Arp2/3 complex as a potential target for further investigation in gastric cancer research.